Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

ClinicalTrials.gov ID: NCT04512066

Public ClinicalTrials.gov record NCT04512066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 4:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Multi-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will investigate the efficacy and safety of RO6889450 as monotherapy in participants experiencing an acute exacerbation of symptoms of schizophrenia or schizoaffective disorder.

Study identification

NCT ID
NCT04512066
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
287 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 7, 2020
Primary completion
Jun 20, 2022
Completion
Jun 20, 2022
Last update posted
Oct 9, 2023

2020 – 2022

United States locations

U.S. sites
24
U.S. states
8
U.S. cities
23
Facility City State ZIP Site status
Woodland International Research Group Inc. Little Rock Arkansas 72211
CITrials, Inc. Bellflower California 90706
ProScience Research Group Culver City California 90230
Collaborative Neuroscience Network, Inc. Garden Grove California 92845
California Clinical Trials Medical Group managed by Parexel Glendale California 91206
Synergy San Diego Lemon Grove California 91945
NRC Research Institute Orange California 92868
ASCLEPES Research Centers Panorama City California 91402
CNRI - Los Angeles, LLC Pico Rivera California 90660
CITrials, Inc. Riverside California 92506
California Neuropsychopharmacology Clinical Research Institute, LLC San Diego California 92102
Artemis Institute For Clinical Research LLC - San Diego - ClinEdge - PPDS San Diego California 92103
Schuster Medical Research Institute Sherman Oaks California 91403
Galiz Research, LLC Hialeah Florida 33016
Innovative Clinical Research, Inc. Lauderhill Florida 33319
Premier Clinical Research Institute - Miami - BTC - PPDS Miami Florida 33122
Research Centers of America - ERG Oakland Park Florida 33334
Atlanta Center For Medical Research Atlanta Georgia 30331
Uptown Research Institute Chicago Illinois 60640
CBH Health LLC Gaithersburg Maryland 20877
Neuro-Behavioral Clinical Research, Inc. Canton Ohio 44718
Midwest Clinical Research Center - ERG - PPDS Dayton Ohio 45415
Community Clinical Research Inc. Austin Texas 78754
Pillar Clinical Research LLC Garland Texas 75042

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04512066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2023 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04512066 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →